Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
Condition: Chronic Myelocytic Leukemia Intervention: Other: RQ-PCR(Real-time Quantitative Polymerase chain reaction) RNA Analysis Sponsors: Seoul St. Mary's Hospital; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials